wca offers a comprehensive range of product registration and regulatory compliance services for chemicals. Our team has extensive experience with regulatory frameworks for chemical management and established relationships with regulatory authorities at national and international level. We successfully guide clients through the complete regulatory life-cycle for chemicals under the following regimes:

Service areas: REACH & CLP,

REACH Regulation

REACH (Registration, Evaluation, Authorisation and restriction of CHemicals), is the European Union programme for the regulation of both new and existing chemical substances on the European market.
Find out more

PBT and vPvB Assessments

Assessment of substance Persistence, Bioaccumulation and Toxicity (PBT) properties is required under different regulations, for industrial chemicals (REACH), veterinary medicines, plant protection products and biocides.
Find out more

Classification Labelling and Packaging (CLP) Regulation

The classification and labelling of chemical substances is undertaken to ensure their safe production, transport, use and disposal in the workplace and by consumers.
Find out more

Service areas: Endocrine Disruption,

Evaluation of Endocrine Disrupting Properties

Endocrine disrupting properties require specific evaluation under European legislation, including the regulation for Plant Protection Products (EC 1107/2009), the revised Biocidal Products Regulation (EU 528/2012), and REACH (EC 1907/2006).
Find out more

Pharmaceutical Environmental Risk & Impact Assessments

An environmental risk assessment (ERA) is required for all marketing authorisation applications for human medicinal products (Article 8(3) of Directive 2001/83/EC). This requirement applies, with some exceptions, to all new medicinal products, as well as new applications for generic medicinal products.
Find out more

Veterinary Medicine Environmental Risk and Impact Assessment

Environmental impact assessments (EIAs) are required for marketing authorisation applications for veterinary medicinal products under Directive 2001/82/EC. This requirement applies to all new veterinary medicines, as well as for existing products requiring a market authorisation renewal.
Find out more

If your particular compliance requirement is not listed above, please contact us and we’d be happy to discuss your needs.

Have a question?

Get in touch